• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The cholinolytic biperiden in depression. An acute placebo controlled study.

作者信息

Beckmann H, Moises H W

出版信息

Arch Psychiatr Nervenkr (1970). 1982;231(3):213-20. doi: 10.1007/BF00343291.

DOI:10.1007/BF00343291
PMID:7044340
Abstract

Clinical and experimental work indicates that cholinergic functions might play a role in modulating affectivity in man. In this acute double-blind study either the cholinolytic agent biperiden or placebo infusions were administered to six depressed females. The Janke and Debus self-rating questionnaire (EWL-K), the modified Hamilton depression scale (HAM-D), and the Montgomery and Asberg depression scale (MADRS) were used for documentation of psychopathological change. There was an acute antidepressant effect during infusion of the active drug in comparison to placebo as measured on the global MADRS and EWL-K, but not on the modified HAM-D. Single items such as depressed mood, work and interests (HAM-D), sadness, concentration difficulties, inability to feel (MADR-S), and depressiveness (EWL-K) responded selectively and significantly to the biperiden infusion. It is concluded that cholinergic activity might be involved in the regulation of affectivity in man.

摘要

相似文献

1
The cholinolytic biperiden in depression. An acute placebo controlled study.
Arch Psychiatr Nervenkr (1970). 1982;231(3):213-20. doi: 10.1007/BF00343291.
2
Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials.蒙哥马利-阿斯伯格抑郁评定量表、汉密尔顿抑郁评定量表及临床总体印象量表在抗抑郁药物临床试验中的相对敏感性
Int Clin Psychopharmacol. 2002 Nov;17(6):281-5. doi: 10.1097/00004850-200211000-00003.
3
The anticholinergic biperiden in depressive disorders.抗胆碱能药物比哌立登在抑郁症中的应用
Pharmacopsychiatria. 1981 Nov;14(6):195-8. doi: 10.1055/s-2007-1019597.
4
Relative sensitivity of the Montgomery-Asberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis.蒙哥马利-阿斯伯格抑郁评定量表、汉密尔顿抑郁评定量表及临床总体印象量表在抗抑郁药物临床试验中的相对敏感性:一项重复分析
Int Clin Psychopharmacol. 2004 May;19(3):157-60. doi: 10.1097/00004850-200405000-00006.
5
No antidepressant effect of biperiden compared with placebo in depression: a double-blind 6-week clinical trial.与安慰剂相比,比哌立登对抑郁症无抗抑郁作用:一项双盲6周临床试验。
Psychiatry Res. 1995 Sep 29;58(2):99-105. doi: 10.1016/0165-1781(95)02700-7.
6
A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.一项关于奈法唑酮治疗重度抑郁症住院患者的双盲、安慰剂对照试验。
J Clin Psychiatry. 1998 May;59(5):246-53. doi: 10.4088/jcp.v59n0508.
7
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.拉莫三嗪单药治疗双相 I 型抑郁症门诊患者的双盲安慰剂对照研究。拉莫三嗪 602 研究组。
J Clin Psychiatry. 1999 Feb;60(2):79-88. doi: 10.4088/jcp.v60n0203.
8
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.抗胆碱能药物东莨菪碱的抗抑郁疗效:一项随机、安慰剂对照临床试验。
Arch Gen Psychiatry. 2006 Oct;63(10):1121-9. doi: 10.1001/archpsyc.63.10.1121.
9
A placebo- and imipramine-controlled study of paroxetine.一项关于帕罗西汀的安慰剂和丙咪嗪对照研究。
Psychopharmacol Bull. 1990;26(2):185-9.
10
Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.喹硫平治疗双相I型或II型抑郁症患者的焦虑症:一项随机、双盲、安慰剂对照研究的二次分析
J Clin Psychiatry. 2006 Mar;67(3):355-62. doi: 10.4088/jcp.v67n0304.

引用本文的文献

1
Clinical Effectiveness of Muscarinic Receptor-Targeted Interventions in Neuropsychiatric Disorders: A Systematic Review.神经精神障碍中毒蕈碱型受体靶向干预的临床疗效:系统评价。
CNS Drugs. 2022 Nov;36(11):1171-1206. doi: 10.1007/s40263-022-00964-8. Epub 2022 Oct 21.
2
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.纹状体内注射肉毒杆菌神经毒素 A 对单侧 6-羟多巴胺帕金森病大鼠模型的抗抑郁样作用。
Toxins (Basel). 2021 Jul 20;13(7):505. doi: 10.3390/toxins13070505.
3
Anti-Parkinson Drug Biperiden Inhibits Enzyme Acetylcholinesterase.

本文引用的文献

1
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
2
Reintegration of affect and psychic emergence with ditran. A clinical report and interpretation of results.用氯氮卓进行情感与心理显现的重新整合。一份临床报告及结果解读。
J Neuropsychiatr. 1962 May-Jun;3:304-10.
3
[Drug therapy of endogenous psychoses].[内源性精神病的药物治疗]
抗帕金森病药物比哌立登可抑制乙酰胆碱酯酶。
Biomed Res Int. 2017;2017:2532764. doi: 10.1155/2017/2532764. Epub 2017 Jul 13.
4
The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?毒蕈碱受体在情绪障碍病理生理学中的作用:一种潜在的新型治疗方法?
Curr Neuropharmacol. 2015;13(6):739-49. doi: 10.2174/1570159x13666150612230045.
5
Review of pharmacological treatment in mood disorders and future directions for drug development.心境障碍的药理学治疗评价及药物研发的未来方向。
Neuropsychopharmacology. 2012 Jan;37(1):77-101. doi: 10.1038/npp.2011.198. Epub 2011 Sep 7.
6
Stem cell approaches in psychiatry--challenges and opportunities.精神病学中的干细胞疗法——挑战与机遇
Dialogues Clin Neurosci. 2009;11(4):397-404. doi: 10.31887/DCNS.2009.11.4/jbenninghoff.
7
Scopolamine as an antidepressant agent: theoretical and treatment considerations.东莨菪碱作为一种抗抑郁药:理论与治疗方面的考量。
Curr Psychiatry Rep. 2007 Dec;9(6):447-8. doi: 10.1007/s11920-007-0060-4.
8
Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.胆碱能神经传递似乎与抑郁症无关,但可能与人格有关。
J Psychiatry Neurosci. 1995 Jan;20(1):39-48.
9
Clinical investigations into antidepressive mechanisms. I. Antihistaminic and cholinolytic effects: amitriptyline versus promethazine.抗抑郁机制的临床研究。I. 抗组胺和抗胆碱作用:阿米替林与异丙嗪的比较。
Arch Psychiatr Nervenkr (1970). 1983;233(1):59-70. doi: 10.1007/BF00540037.
10
Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells.
Eur Arch Psychiatry Neurol Sci. 1988;237(4):209-17. doi: 10.1007/BF00449909.
Nervenarzt. 1959 Jun 20;30(6):241-5.
4
Some effects of a new psychotogen in depressive states.一种新型致幻剂在抑郁状态中的某些作用。
J Nerv Ment Dis. 1958 Dec;127(6):546-50. doi: 10.1097/00005053-195812000-00008.
5
[1-(Bicyclo [2,2,1] hept-5-en-2-yl)-1-phenyl-3-piperidino-1-propanol (akineton)].[1 -(双环[2,2,1]庚 - 5 - 烯 - 2 - 基)- 1 - 苯基 - 3 - 哌啶基 - 1 - 丙醇(安坦)]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;226(1):18-35.
6
The anticholinergic biperiden in depressive disorders.抗胆碱能药物比哌立登在抑郁症中的应用
Pharmacopsychiatria. 1981 Nov;14(6):195-8. doi: 10.1055/s-2007-1019597.
7
Clinical notes on the possible anticholinergic reversal of depressive syndromes.关于抑郁综合征可能的抗胆碱能逆转的临床记录。
Pharmacopsychiatria. 1981 Mar;14(2):71-3. doi: 10.1055/s-2007-1019569.
8
Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.大鼠脑突触体对儿茶酚胺的摄取。对多巴胺能和去甲肾上腺素能神经元有不同作用的药物的构效关系。
Mol Pharmacol. 1971 Jan;7(1):66-80.
9
Diagnostic criteria for use in psychiatric research.精神科研究中使用的诊断标准。
Arch Gen Psychiatry. 1972 Jan;26(1):57-63. doi: 10.1001/archpsyc.1972.01750190059011.
10
[The specific psychical effect of psycholeptics. Report on the results of 33 long-term personal tests with neuroleptics, thymoleptics, anti-parkinson agents and placebos].
Hippokrates. 1966 Apr 30;37(8):285-90.